Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KA2 | Q15349 | 10/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8556336 | 0.93 | RXRA (0.41) | RPS6KA2RXRAELANEPTGES2CA12 | |
| SCHEMBL8556682 | 0.93 | RPS6KA2 (0.43) | RPS6KA2RXRAELANEPTGES2CA12 | |
| SCHEMBL8557881 | 0.90 | ALPL (0.36) | ELANEPTGES2CA12CA1CA2 | |
| SCHEMBL8555338 | 0.89 | RXRA (0.38) | RXRAELANEPTGES2CA12CA1 | |
| SCHEMBL8561044 | 0.88 | NPC1 (0.38) | RXRACA12CA1CA2CA9 | |
| SCHEMBL8555069 | 0.87 | RXRA (0.43) | RPS6KA2RXRAELANECA12CA1 | |
| SCHEMBL8559802 | 0.87 | RXRA (0.49) | RXRAPTGES2CA12CA1CA2 | |
| SCHEMBL8559484 | 0.87 | CA12 (0.37) | RPS6KA2RXRAPTGES2CA12CA1 | |
| SCHEMBL8557954 | 0.85 | RXRA (0.47) | RXRACA12CA1CA2CA9 | |
| SCHEMBL7504101 | 0.85 | CA2 (0.47) | RPS6KA2RXRACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5719163-A | ARTHRITIS | G.D. SEARLE & CO. (US) | 1998-02-17 | — | — | US | disclosed |